Published in Mol Immunol on September 17, 2007
Src-family and Syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk. Cold Spring Harb Perspect Biol (2011) 1.38
Multiple roles of Lyn kinase in myeloid cell signaling and function. Immunol Rev (2009) 1.25
Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci (2014) 1.18
Src kinase-targeted anti-inflammatory activity of davallialactone from Inonotus xeranticus in lipopolysaccharide-activated RAW264.7 cells. Br J Pharmacol (2008) 1.11
Alcohol-induced interactive phosphorylation of Src and toll-like receptor regulates the secretion of inflammatory mediators by human astrocytes. J Neuroimmune Pharmacol (2010) 1.09
Cell signalling in macrophages, the principal innate immune effector cells of rheumatoid arthritis. Arthritis Res Ther (2008) 1.09
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice. Gastroenterology (2011) 1.07
E3 ubiquitin ligase CHIP facilitates Toll-like receptor signaling by recruiting and polyubiquitinating Src and atypical PKC{zeta}. J Exp Med (2011) 1.05
Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation. Proc Natl Acad Sci U S A (2013) 1.03
α1-adrenergic receptors positively regulate Toll-like receptor cytokine production from human monocytes and macrophages. J Pharmacol Exp Ther (2011) 0.96
Dynamic modulation of innate immune response by varying dosages of lipopolysaccharide (LPS) in human monocytic cells. J Biol Chem (2014) 0.94
p38 MAPK inhibition suppresses the TLR-hypersensitive phenotype in FANCC- and FANCA-deficient mononuclear phagocytes. Blood (2012) 0.91
Tyrosine phosphorylation in Toll-like receptor signaling. Cytokine Growth Factor Rev (2014) 0.90
Src kinase participates in LPS-induced activation of NADPH oxidase. Mol Immunol (2009) 0.89
Themis2/ICB1 is a signaling scaffold that selectively regulates macrophage Toll-like receptor signaling and cytokine production. PLoS One (2010) 0.88
Extracellular cholesterol-rich microdomains generated by human macrophages and their potential function in reverse cholesterol transport. J Lipid Res (2010) 0.87
Src kinases are required for a balanced production of IL-12/IL-23 in human dendritic cells activated by Toll-like receptor agonists. PLoS One (2010) 0.86
Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1. Inflamm Bowel Dis (2011) 0.85
Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells. Oncotarget (2015) 0.82
ATP-Binding Pocket-Targeted Suppression of Src and Syk by Luteolin Contributes to Its Anti-Inflammatory Action. Mediators Inflamm (2015) 0.81
Mediators of Tyrosine Phosphorylation in Innate Immunity: From Host Defense to Inflammation onto Oncogenesis. Curr Signal Transduct Ther (2009) 0.78
Pharmacological Inactivation of Src Family Kinases Inhibits LPS-Induced TNF-α Production in PBMC of Patients with Behçet's Disease. Mediators Inflamm (2016) 0.75
Association of Lyn kinase with membrane rafts determines its negative influence on LPS-induced signaling. Mol Biol Cell (2017) 0.75
Targeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology. mSphere (2016) 0.75
PKC and AKT Modulate cGMP/PKG Signaling Pathway on Platelet Aggregation in Experimental Sepsis. PLoS One (2015) 0.75
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol (2011) 5.11
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med (2009) 3.58
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet (2005) 2.93
Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci U S A (2010) 2.70
TNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells. Proc Natl Acad Sci U S A (2011) 2.33
Interleukin-10 suppression of myeloid cell activation--a continuing puzzle. Immunology (2004) 1.95
Cutting edge: A transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. J Immunol (2007) 1.62
Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Miner Res (2004) 1.45
Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J Immunol (2006) 1.43
Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production. J Exp Med (2003) 1.43
Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis. Arthritis Rheum (2002) 1.40
Expression of constitutively active STAT3 can replicate the cytokine-suppressive activity of interleukin-10 in human primary macrophages. J Biol Chem (2006) 1.38
Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis. Circulation (2009) 1.38
Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood (2010) 1.37
IL-10 induces IL-10 in primary human monocyte-derived macrophages via the transcription factor Stat3. J Immunol (2007) 1.34
Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages. J Immunol (2002) 1.29
A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis. J Immunol (2004) 1.26
Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. J Leukoc Biol (2004) 1.25
Tyrosine kinases and inflammatory signalling. Curr Mol Med (2009) 1.25
The role of transposable elements in the regulation of IFN-lambda1 gene expression. Proc Natl Acad Sci U S A (2009) 1.24
Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol (2005) 1.15
Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism. J Immunol (2009) 1.15
Potential of mesenchymal stem cell therapy. Curr Opin Oncol (2007) 1.14
Th17 cells, not IL-17+ γδ T cells, drive arthritic bone destruction in mice and humans. J Immunol (2011) 1.14
Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation. PLoS One (2012) 1.13
Bmx tyrosine kinase regulates TLR4-induced IL-6 production in human macrophages independently of p38 MAPK and NFkapp}B activity. Blood (2007) 1.11
IL-10 inhibits transcription elongation of the human TNF gene in primary macrophages. J Exp Med (2010) 1.07
Anti-TNF therapy: where have we got to in 2005? J Autoimmun (2005) 1.07
TNFalpha-induced macrophage chemokine secretion is more dependent on NF-kappaB expression than lipopolysaccharides-induced macrophage chemokine secretion. Eur J Immunol (2002) 1.06
Rac mediates TNF-induced cytokine production via modulation of NF-kappaB. Mol Immunol (2008) 1.03
Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6. J Am Soc Nephrol (2007) 1.01
Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo? Arthritis Rheum (2010) 1.00
SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis. Arthritis Rheum (2010) 0.94
Nuclear factor-kappaB activation in alveolar macrophages requires IkappaB kinase-beta, but not nuclear factor-kappaB inducing kinase. Am J Respir Crit Care Med (2002) 0.93
Nonsteroidal anti-inflammatory drugs increase TNF production in rheumatoid synovial membrane cultures and whole blood. J Immunol (2010) 0.93
Potential of rifamides to inhibit TNF-induced NF-kappaB activation. J Antimicrob Chemother (2002) 0.93
IL-4 regulation of p38 MAPK signalling is dependent on cell type. Cytokine (2002) 0.91
Elevated cytokine production restores bone resorption by human Btk-deficient osteoclasts. J Bone Miner Res (2011) 0.91
Hck tyrosine kinase regulates TLR4-induced TNF and IL-6 production via AP-1. J Immunol (2011) 0.91
T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NFkappaB: implications for rheumatoid arthritis. Arthritis Res Ther (2006) 0.91
Dual-specificity phosphatase 1-null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis. Arthritis Rheum (2012) 0.90
A late, prolonged activation of the phosphatidylinositol 3-kinase pathway is required for T cell proliferation. J Immunol (2004) 0.89
Could toll-like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissue. Ann Rheum Dis (2007) 0.86
OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis. Proc Natl Acad Sci U S A (2014) 0.86
Cells of the immune system orchestrate changes in bone cell function. Calcif Tissue Int (2013) 0.85
Bmx regulates LPS-induced IL-6 and VEGF production via mRNA stability in rheumatoid synovial fibroblasts. Biochem Biophys Res Commun (2008) 0.83
Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease. J Clin Invest (2015) 0.81
RelB/p50 regulates CCL19 production, but fails to promote human DC maturation. Eur J Immunol (2009) 0.81
T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis. J Bone Miner Res (2003) 0.81
Raised circulating tenascin-C in rheumatoid arthritis. Arthritis Res Ther (2012) 0.80
Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta. Stem Cells Dev (2013) 0.79
Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases. Front Endocrinol (Lausanne) (2012) 0.76
High-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets. Arthritis Res (2002) 0.75
Adenoviral targeting of signal transduction pathways in synovial cell cultures. Methods Mol Med (2007) 0.75